NCT05095389View on ClinicalTrials.gov

Adipose Derived Regenerative Cells In the Treatment of Diabetic Foot Ulcers

PHASE3UnknownINTERVENTIONAL

Enrollment

290

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

July 31, 2025

Conditions

Diabetic Foot Ulcer

Interventions

DEVICE

ADRCs

Administration of Autologous Adipose Derived Regenerative Cells into the Diabetic Foot Ulcer

OTHER

standard care

standard care

OTHER

Placebo

placebo

Sponsors

Lead Sponsor

Paracrine, INC.

All Listed Sponsors

lead

Paracrine, INC.

INDUSTRY

NCT05095389 - Adipose Derived Regenerative Cells In the Treatment of Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter